Drugs / Convalescent anti-SARS-CoV-2 plasma
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04345289 Comparator | May 2020 → Mar 2021 | COVID-19, viral pneumonia | Thomas Benfield | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Convalescent anti-SARS-CoV-2 plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04345289 ↗ |